Karen Tuesley

Postdoctoral Research Fellow, cancer epidemiology, women's health, @UQMedicine Views are my own

[Karen Tuesley @TuesleyK]

Here's the link to our latest publication on the association between osteoporosis medicines and cancer. https://t.co/SNAX2j1Jza

[JNCI @JNCI_Now]

🥇 And finally, our most viewed article last year:

Do long-acting contraceptives alter cancer risk?

Nationwide data show a profile similar to the oral pill:
⬇️ ovarian and endometrial risk, but
⬆️ short-term breast cancer risk.

https://t.co/ax5OhCqNTW
#WomensHealth

[Karen Tuesley @TuesleyK]

Link to our recently published paper: https://t.co/ZDbTPaPEYs
https://t.co/QhIdT0O7AL

[Karen Tuesley @TuesleyK]

@UQ_News @QIMRB_Institute @UQMedicine @ConversationEDU Link to our study: https://t.co/PR6VRNzShL

[UQ News @UQ_News]

Research from #UQ's @TuesleyK and Prof Susan Jordan and @QIMRB_Institute has looked into the cancer risk for long-term contraceptive users. @UQMedicine

Via @ConversationEDU
https://t.co/XcXc6kbKoh

[Karen Tuesley @TuesleyK]

Sharing our recently published paper: Exploring estrogen-related mechanisms in ovarian carcinogenesis: association between bone mineral density and ovarian cancer risk in a multivariable Mendelian randomization study.
https://t.co/nmJXOmEkPj

[Karen Tuesley @TuesleyK]

Why are tall people more likely to get cancer? What we know, don’t know and suspect https://t.co/na5tRxvS68 via @ConversationEDU

[Karen Tuesley @TuesleyK]

Check out our paper that has just been published in IJE. "Use of an emulated trial to investigate the association between use of nitrogen-based bisphosphonates and risk of epithelial ovarian cancer" https://t.co/mI76Upks3F

[Karen Tuesley @TuesleyK]

Rapid access oral health trial shows promise for ED patients https://t.co/dxBZuKa3JE

[Women's Health Research Translation&Impact Network @whrtn_ahra]

We are delighted that another 4 women's health researchers have received #WHRTN 2023 EMCR Awards.  Congratulations, Sarah Lang, Maleesa Pathirana, Zohra Lassi & Karen Tuesley & all 2023 awardees. Read the full list: https://t.co/goBfNMKmoV

[Karen Tuesley @TuesleyK]

Highlights:
•Most antihypertensive medicines were not associated with ovarian cancer risk.
•Use of calcium channel blockers were associated with decreased risk of serous ovarian cancers.
•Thiazide/potassium-sparing diuretics doubled the risk of endometrioid ovarian cancer.

[Karen Tuesley @TuesleyK]

Here is the link to our study: Association between antihypertensive medicine use and risk of ovarian cancer in women aged 50 years and older.
https://t.co/5gXuievx5T
@susanjanejordan @UQMedicine

[AustralasianEpi @AustralasianEpi]

ECR? Cancer epidemiologist? AEA member? Check this out 👇

[Azam Majidi @_azammajidi]

Our study just published in @JNCI_Now suggest a possible #survival advantage for women diagnosed with #ovariancancer who use daily low-dose #aspirin or other #NSAIDs after diagnosis.
@QIMRBerghofer https://t.co/ncoleo47hi
https://t.co/WnFFOgyPRM

[Karen Tuesley @TuesleyK]

Our new paper in @JCO_ASCO shows non-selective beta-blockers used around time of surgery for ovarian cancer may improve survival. https://t.co/87rxyPqEHK

[Susan Jordan @susanjanejordan]

Our new paper in @JCO_ASCO shows non-selective beta-blockers used around time of surgery for ovarian cancer may improve survival. Check it out here 👇
10.1200/JCO.22.00097

@TuesleyK @UQMedicine

[Karen Tuesley @TuesleyK]

Here is the link to our manuscript:
https://t.co/3BgM94skmR

@susanjanejordan

[UQ News @UQ_News]

#UQ research finds a link between osteoporosis medications and lower rates of ovarian cancer

Read more here👇
https://t.co/TSogsJDRfC

@UQHealth @TuesleyK @susanjanejordan

[Karen Tuesley @TuesleyK]

Nitrogen-based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older https://t.co/55h8zX9dbu

[UQ News @UQ_News]

#UQ research finds a link between osteoporosis medications and lower rates of ovarian cancer

Read more here👇
https://t.co/TSogsJDRfC

@UQHealth @TuesleyK @susanjanejordan